Long-term tracking of murine hematopoietic cells transduced with a bicistronic retrovirus containing CD24 and EGFP genes

[1]  A. Nienhuis,et al.  High levels of lymphoid expression of enhanced green fluorescent protein in nonhuman primates transplanted with cytokine-mobilized peripheral blood CD34(+) cells. , 2000, Blood.

[2]  T. Suda,et al.  Green Fluorescent Protein as a Selectable Marker of Retrovirally Transduced Hematopoietic Progenitors , 1999, Stem cells.

[3]  K. Matsuda,et al.  A selective amplifier gene for tamoxifen‐inducible expansion of hematopoietic cells , 1999, The journal of gene medicine.

[4]  D. Kohn,et al.  Immune response to green fluorescent protein: implications for gene therapy , 1999, Gene Therapy.

[5]  K. Matsuda,et al.  Development of a modified selective amplifier gene for hematopoietic stem cell gene therapy , 1999, Gene Therapy.

[6]  H. Mizukami,et al.  Hematopoietic stem cell gene therapy: a current overview. , 1999, International journal of hematology.

[7]  S. Karlsson,et al.  No discrepancy between in vivo gene marking efficiency assessed in peripheral blood populations compared with bone marrow progenitors or CD34+ cells. , 1999, Human gene therapy.

[8]  R. Ashmun,et al.  In vivo selection of retrovirally transduced hematopoietic stem cells , 1998, Nature Medicine.

[9]  L. Lum,et al.  T cell activation modulates retrovirus-mediated gene expression. , 1998, Human gene therapy.

[10]  K. Weinberg,et al.  T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates , 1998, Nature Medicine.

[11]  X. Breakefield,et al.  Long-term expression of the gene encoding green fluorescent protein in murine hematopoietic cells using retroviral gene transfer. , 1998, Transplantation.

[12]  A. Stewart,et al.  Retrovirus-mediated gene transfer into human hematopoietic stem cells , 1998, Journal of Molecular Medicine.

[13]  H. Mano,et al.  Development of a novel selective amplifier gene for controllable expansion of transduced hematopoietic cells. , 1997, Blood.

[14]  G. Wagemaker,et al.  Enhanced green fluorescent protein as selectable marker of retroviral-mediated gene transfer in immature hematopoietic bone marrow cells. , 1997, Blood.

[15]  A. Nomoto,et al.  A novel dicistronic AAV vector using a short IRES segment derived from hepatitis C virus genome. , 1997, Gene.

[16]  Richard J Smeyne,et al.  Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. , 1997, Blood.

[17]  R. Morgan,et al.  A simple and reliable method for screening retroviral producer clones without selectable markers. , 1997, Human gene therapy.

[18]  C. Bordignon,et al.  HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. , 1997, Science.

[19]  S. Kain,et al.  Optimized codon usage and chromophore mutations provide enhanced sensitivity with the green fluorescent protein. , 1996, Nucleic acids research.

[20]  E. Gilboa,et al.  Cell–surface markers for assessing gene transfer into human hematopoietic cells , 1996, Nature Medicine.

[21]  D. Bodine,et al.  The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Dinauer,et al.  High-level reconstitution of respiratory burst activity in a human X-linked chronic granulomatous disease (X-CGD) cell line and correction of murine X-CGD bone marrow cells by retroviral-mediated gene transfer of human gp91phox. , 1996, Blood.

[23]  David A. Williams,et al.  Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells , 1996, Nature Medicine.

[24]  T. Reynolds,et al.  T–cell mediated rejection of gene–modified HIV–specific cytotoxic T lymphocytes in HIV–infected patients , 1996, Nature Medicine.

[25]  S. Karlsson,et al.  Selection of transduced CD34+ progenitors and enzymatic correction of cells from Gaucher patients, with bicistronic vectors. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R Y Tsien,et al.  Understanding, improving and using green fluorescent proteins. , 1995, Trends in biochemical sciences.

[27]  G. Nolan,et al.  Efficient screening of retroviral cDNA expression libraries. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Nienhuis,et al.  Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. , 1995, Blood.

[29]  L. Zitvogel,et al.  Construction and characterization of retroviral vectors expressing biologically active human interleukin-12. , 1994, Human gene therapy.

[30]  P. Lansdorp,et al.  Selection of retrovirally transduced hematopoietic cells using CD24 as a marker of gene transfer. , 1994, Blood.

[31]  T. Hawley,et al.  Versatile retroviral vectors for potential use in gene therapy. , 1994, Gene therapy.

[32]  M. Chalfie,et al.  Green fluorescent protein as a marker for gene expression. , 1994, Science.

[33]  M. Hoffman,et al.  Sequence and structural elements that contribute to efficient encephalomyocarditis virus RNA translation , 1992, Journal of virology.

[34]  C. Cepko,et al.  A recombinant retrovirus encoding alkaline phosphatase confirms clonal boundary assignment in lineage analysis of murine retina. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Karlsson,et al.  Treatment of genetic defects in hematopoietic cell function by gene transfer. , 1991, Blood.

[36]  K. Nagase,et al.  High-Level Direct Expression of Semi-Synthetic Human Interleukin-6 in Escherichia coli and Production of N-Terminus Met-Free Product , 1990, Bio/Technology.

[37]  R. Strair,et al.  Retroviral mediated gene transfer into bone marrow progenitor cells: use of beta-galactosidase as a selectable marker. , 1990, Nucleic acids research.

[38]  A. Miller,et al.  Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection , 1990, Molecular and cellular biology.

[39]  Ihor R. Lemischka,et al.  Developmental potential and dynamic behavior of hematopoietic stem cells , 1986, Cell.

[40]  R. Heim,et al.  Understanding structure-function relationships in the Aequorea victoria green fluorescent protein. , 1999, Methods in cell biology.

[41]  N. Young,et al.  Gene marking and gene therapy directed at primary hematopoietic cells , 1996, Current opinion in hematology.

[42]  S. Karlsson,et al.  Retroviral vector design for long-term expression in murine hematopoietic cells in vivo. , 1994, Blood.

[43]  G. Nolan,et al.  Production of high-titer helper-free retroviruses by transient transfection. , 1993, Proceedings of the National Academy of Sciences of the United States of America.